PepsiCo on April 16 reported first-quarter results that topped Street expectations as its North America food business returned to volume growth. Adjusted EPS was $1.61 versus $1.55 expected and revenue rose to $19.44 billion, up 8.5% year‑on‑year. Net income attributable to the company was about $2.33 billion ($1.70 per share). Organic revenue increased 2.6%, supported by the acquisition of Poppi and new product distribution, while North America Foods volume grew roughly 2% after targeted price cuts of up to about 15% on brands including Lay’s, Doritos and Tostitos. North America beverages saw volume decline about 2.5%. Management reiterated full‑year guidance for organic revenue growth of 2–4% and core EPS growth of 4–6%, flagged ongoing inflation and geopolitical uncertainty related to the Middle East, and said systematic commodity hedges and productivity programs should provide near‑term visibility. The company also signalled a Gatorade brand restage and continued investment in growth platforms; shares and options activity rose on the news and institutional buying was highlighted in filings.

Netflix co-founder and chairman Reed Hastings will not stand for re-election when his board term expires in June, the company said on April 16, 2026, marking the formal end of a near-30-year association that transformed Netflix from a DVD-by-mail start-up to a global streaming giant. The announcement accompanied first-quarter results showing revenue of $12.25 billion (up about 16% year-on-year) and net income of $5.28 billion, boosted in part by a $2.8 billion termination fee after Netflix withdrew from a bid for Warner Bros. Discovery. Management warned that second-quarter earnings would fall short of analyst forecasts, sending shares down roughly 8–9% in after-hours trading. Netflix reiterated its strategic priorities — more programming, technology-led experiences including generative AI and a planned mobile revamp, and monetisation via an expanding ad business it expects to deliver about $3 billion in 2026 — while exploring live sports, video podcasts and games as growth levers. Hastings said he will focus on philanthropy and other pursuits after leaving the board.

April 16, 2026 — Abbott Laboratories trimmed its full-year adjusted profit forecast after completing its acquisition of cancer-test maker Exact Sciences, saying the deal will reduce 2026 earnings by about $0.20 a share. Abbott now expects adjusted EPS of $5.38 to $5.58, down from a prior range of $5.55 to $5.80. The company reported first-quarter revenue of roughly $11.2 billion and adjusted EPS of $1.15, narrowly beating estimates. Diagnostics revenue was about $2.18 billion and medical devices revenue roughly $5.54 billion, while the nutrition business showed continued weakness. Management said the Exact Sciences purchase — valued at roughly $21–23 billion in reported coverage — could add about $3 billion in incremental sales in 2026 but has brought near-term financing and dilution pressures. The guidance revision and acquisition timing prompted an intraday share decline of around 4–6% and sparked investor concern. Abbott also noted limited logistics disruption from the Middle East conflict and said it has boosted local inventories to mitigate supply risks.

Apple’s iPhone shipments in China rose 20% year-on-year in the first quarter, the strongest growth among major vendors, Counterpoint Research data showed on April 17. The gain pushed Apple to about a 19% market share, close behind Huawei which retained the top spot with a 20% share and modest 2% growth. The overall Chinese smartphone market contracted roughly 4% in Q1 amid supply-chain disruptions and sharply higher memory-chip costs that have forced many vendors to raise prices. Competitors posted mixed results: Xiaomi plunged about 35% (partly due to a tough year-earlier base), Oppo and Honor fell 5% and 3% respectively, while Vivo rose 2% supported by Lunar New Year sales. Analysts said Apple’s durability perception, promotional pricing around the iPhone 17 series and deeper ability to absorb component cost pressures helped it outperform. Counterpoint and market-watchers warned of further headwinds in Q2 as memory-cost inflation and pricing moves by Chinese brands persist.

Global equity markets rallied on April 15-16, 2026, as hopes for a de-escalation in the U.S.-Iran conflict and a Reuters-reported 10-day Israel-Lebanon ceasefire propelled the S&P 500 and Nasdaq Composite to fresh closing and intraday records. The S&P closed above 7,000 and the Nasdaq notched multi-session winning streaks (11-12 days), while small-cap Russell 2000 also reached record highs. The move was supported by resilient corporate earnings — banks including Morgan Stanley and Bank of America, and PepsiCo surprised on the upside — and stronger-than-expected U.S. jobs data. At the same time oil prices rose (Brent near $99.39, U.S. crude around $94.69) as flows through the Strait of Hormuz remained constrained and global supply buffers tightened. Safe-haven assets and Treasuries eased as risk appetite returned; the dollar retraced some declines. Strategists cautioned that markets were still highly sensitive to news from the Middle East and that further concrete progress on negotiations would be needed to sustain the rally.